Boston Scientific Corporation is an American medical device manufacturer. The company offers solutions for the following medical specialties: electrophysiology, gastroenterology, vascular surgery, gynecology, interventional cardiology, interventional radiology, female pelvic medicine, neurological surgery, orthopedic surgery, pulmology, pain medicine, structural heart, urology.
According to Boston Scientific's latest financial reports and stock price the company's current Operating Margin is 11.27%. At the end of 2022 the company had an Operating Margin of 9.00%.
Year | Operating Margin | Change |
---|---|---|
2022 | 9.00% | -0.6% |
2021 | 9.05% | -750.17% |
2020 | -1.39% | -121.75% |
2019 | 6.40% | -55.79% |
2018 | 14.48% | 40.39% |
2017 | 10.31% | 388.55% |
2016 | 2.11% | -124.28% |
2015 | -8.69% | -805.02% |
2014 | 1.23% | -139.5% |
2013 | -3.12% | -94.49% |
2012 | -56.66% | -772.64% |
2011 | 8.42% | -161.85% |
2010 | -13.62% | -14.75% |
2009 | -15.97% | -37.64% |
2008 | -25.61% | 276.21% |
2007 | -6.81% | -84.94% |
2006 | -45.20% | -418.73% |
2005 | 14.18% | -46.62% |
2004 | 26.56% | 43.61% |
2003 | 18.50% | -1.65% |
2002 | 18.81% | 1042.57% |
2001 | 1.65% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() Medtronic MDT | 17.17% | 52.35% | ๐ฎ๐ช Ireland |
![]() Edwards Lifesciences EW | 31.50% | 179.50% | ๐บ๐ธ USA |
![]() Stryker Corporation SYK | 16.21% | 43.83% | ๐บ๐ธ USA |
![]() Teleflex TFX | 15.97% | 41.70% | ๐บ๐ธ USA |
![]() Merit Medical MMSI | 7.17% | -36.38% | ๐บ๐ธ USA |
![]() AngioDynamics ANGO | -11.74% | -204.17% | ๐บ๐ธ USA |
![]() CONMED CNMD | -6.77% | -160.07% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.